# Metabolic engineering Rational design and optimization of microbial metabolic pathways to produce high-value chemicals, advanced materials, and alternative proteins at industrial scale. Source: https://en.bioecon.ru/technology/metabolic-engineering/ Updated: 2026-08-18 ## Overview and value chain Markers: [EC: 20.14 | OECD: industrial-biotech | Regulator: EPA (US), NMPA (China), EFSA (EU)] Metabolic engineering is the foundational technology of industrial biotechnology, enabling the rational design and optimization of cellular pathways to transform microorganisms into highly efficient bio-factories. By precisely editing the genomes of host organisms such as *E. coli*, *Saccharomyces cerevisiae*, or *Corynebacterium glutamicum*, scientists can divert carbon fluxes toward the synthesis of valuable target molecules, achieving yields that exceed 80% of the theoretical maximum. The process integrates advanced bioinformatics, CRISPR-Cas9 genome editing, and machine learning to map out and construct entirely non-natural metabolic routes. Operating in bioreactors ranging from 1,000 to over 500,000 liters, metabolically engineered strains produce amino acids, bio-polymers, organic acids, and pharmaceutical precursors, fundamentally shifting the chemical industry away from petrochemical dependency and toward sustainable, bio-based feedstocks. The key directions of metabolic engineering are: 1. **Strain Engineering (Cell Programming):** Utilizing high-throughput robotics and machine learning to rapidly prototype and test millions of genetic variants. 2. **C1 Gas Fermentation:** Engineering acetogenic bacteria to metabolize industrial off-gases (CO, CO2) directly into ethanol and platform chemicals. 3. **Precision Fermentation:** Optimizing yeast and fungal strains for the high-yield production of complex nutritional molecules, flavors, and vitamins. 4. **Bio-based Monomers:** Rerouting metabolic fluxes to synthesize long-chain dicarboxylic acids and diamines for high-performance bio-polyamides. ### Sectoral value chain ``` [Strain Design] ──> [Pathway Optimization] ──> [Pilot Fermentation] ──> [Scale-up] │ (Platform Chemicals) │ ▼ [Consumer Goods] <─── [Downstream Processing] <─────┘ ``` ### Value chain levels | Level | Description | Key inputs/outputs | |:---|:---|:---| | **1. Strain Design** | Computational modeling and genetic editing of the host chassis | **In:** Wild-type strain, DNA constructs.
**Out:** Engineered microbe. | | **2. Pathway Optimization** | Fine-tuning gene expression and balancing metabolic fluxes | **In:** Engineered microbe.
**Out:** High-yield producer strain. | | **3. Pilot Fermentation** | Testing the strain in 10L to 1,000L bioreactors under dynamic conditions | **In:** Producer strain, feedstocks.
**Out:** Pilot fermentation broth. | | **4. Scale-up** | Transferring the bioprocess to massive commercial-scale fermenters (>100,000L) | **In:** Pilot broth, bulk sugars/gases.
**Out:** Commercial fermentation broth. | | **5. Downstream Processing** | Centrifugation, filtration, and crystallization of the target molecule | **In:** Commercial fermentation broth.
**Out:** Purified bio-compound. | | **6. Application Integration** | Formulating the pure compound into final industrial or consumer products | **In:** Purified bio-compound.
**Out:** End-user products. | Cross-cutting technologies of the sector: - **CRISPR-Cas Multiplexing:** simultaneous editing of multiple target genes to rewire complex metabolic networks in a single generation. - **High-Throughput Screening (HTS):** automated microfluidic systems coupled with mass spectrometry to evaluate the productivity of thousands of strains daily. - **Flux Balance Analysis (FBA):** mathematical modeling of intracellular metabolic networks to predict optimal gene knockout and overexpression strategies. --- ## US The US leads the global market in cell programming platforms and the commercialization of novel gas fermentation technologies, backed by massive venture capital. ### cell programming, gas fermentation, synthetic biology hubs - **Ginkgo Bioworks Foundry:** operating a massive, automated platform ("The Foundry") that provides custom strain engineering as a service to global chemical and pharma giants. - **LanzaTech CarbonSmart:** pioneering commercial-scale gas fermentation by deploying engineered acetogens at steel mills to capture and convert emissions into chemical building blocks. - **Department of Energy (DOE) Grants:** heavy federal funding driving the development of robust microbial chassis capable of utilizing diverse, low-cost lignocellulosic feedstocks. --- ## CN China aggressively scales metabolic engineering to dominate the global supply of amino acids, organic acids, and bio-based polyamides, aiming for industrial self-sufficiency. ### bio-manufacturing scale, amino acids, synthetic biology parks - **Cathay Biotech Polyamides:** leading the global commercialization of bio-based long-chain diacids and bio-polyamides through proprietary engineered strains. - **Huaheng Bio Dominance:** utilizing highly optimized anaerobic fermentation processes to become the world's largest producer of L-alanine and other high-value amino acids. - **State-Sponsored SynBio Hubs:** massive government investments in synthetic biology innovation centers in Shenzhen and Tianjin to accelerate the translation from lab to mega-factory. --- ## EU The EU focuses on the precision fermentation of high-value nutritional ingredients and sustainable surfactants, driven by strict green chemistry mandates. ### precision fermentation, bio-surfactants, circular bioeconomy - **Evonik Biosurfactants:** deploying advanced metabolic engineering to produce 100% bio-based and biodegradable rhamnolipids at commercial scale in Slovakia. - **DSM-Firmenich Nutrition:** utilizing rationally designed yeast and fungal strains for the direct, sustainable synthesis of vitamins, carotenoids, and complex flavor profiles. - **Circular Bio-based Europe (CBE JU):** public-private partnerships funding the development of cell factories that convert agricultural residues into drop-in chemicals. --- ## Leading companies and research institutes | Company / Institute | Country | Key products / platforms | Tech features | Status 2026 | |:---|:---|:---|:---|:---| | **Ginkgo Bioworks** | 🇺🇸 USA | *Codebase & Foundry* | Automated multiplex strain engineering | commercial | | **LanzaTech** | 🇺🇸 USA | *CarbonSmart ethanol* | Continuous gas fermentation reactors | commercial | | **Evonik** | 🇩🇪 Germany | *Rhamnolipids, amino acids* | Precision pathway optimization | commercial | | **DSM-Firmenich** | 🇳🇱 Netherlands | *Vitamins, flavors, enzymes* | Rational design of fungal chassis | commercial | | **Cathay Biotech** | 🇨🇳 China | *Bio-polyamides (Terryl)* | High-yield long-chain diacid pathways | commercial | | **Huaheng Bio** | 🇨🇳 China | *L-alanine, valine* | Anaerobic highly efficient fermentation | commercial | --- ## Tech stack and innovations Metabolic engineering relies on the seamless integration of computational biology, advanced molecular tools, and highly monitored bioprocessing. 1. **Computational Strain Design:** - Algorithms predict the theoretical maximum yields of target molecules using genome-scale metabolic models (GEMs) comprising over 3,000 biochemical reactions. - Machine learning models analyze transcriptomic and metabolomic data to identify regulatory bottlenecks and non-obvious gene targets for disruption. 2. **Genetic Assembly and Editing:** - Automated DNA synthesis and modular assembly techniques (like Golden Gate) construct vast libraries of pathway variants containing different promoters and terminators. - CRISPR-associated transposases allow for the stable, multiplexed integration of large biosynthetic gene clusters directly into the host chromosome. 3. **Bioreactor Process Control:** - Multi-omics sensors continuously monitor pH, dissolved oxygen, and specific metabolite concentrations in real-time. - Dynamic control strategies, such as optogenetics, use light to independently switch metabolic pathways from a "growth phase" to a "production phase" maximizing yields. --- ## Value chains and production pipelines ### Industrial pipeline of microbial cell factories (ISO 23418) ``` ┌───────────────────────────┐ ┌───────────────────────────┐ │ 1. In silico design │ ───> │ 2. Genetic construction │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 4. Pilot optimization │ <─── │ 3. High-throughput screen │ └───────────────────────────┘ └───────────────────────────┘ │ ▼ ┌───────────────────────────┐ ┌───────────────────────────┐ │ 5. Industrial scale-up │ ───> │ 6. Recovery & formulation │ └───────────────────────────┘ └───────────────────────────┘ ``` #### Stage 1: In silico design Running flux balance analysis on the selected microbial chassis to identify the optimal gene knockouts and insertions required to maximize the carbon flow to the target molecule. #### Stage 2: Genetic construction Synthesizing the designed DNA cassettes and seamlessly integrating them into the host genome using CRISPR-Cas9 to create a library of 10,000 distinct prototype strains. #### Stage 3: High-throughput screen Cultivating the engineered strains in automated micro-bioreactors (1-10 mL) while mass spectrometry rapidly quantifies the target molecule titer to identify the top 5 performers. #### Stage 4: Pilot optimization Transferring the winning strains into 1,000-liter pilot fermenters to fine-tune the feeding strategy, aeration rates, and dynamic pathway regulation under realistic industrial conditions. #### Stage 5: Industrial scale-up Inoculating massive 500,000-liter commercial bioreactors with the optimized strain and continuously feeding it low-cost sugars or captured off-gases to achieve maximum volumetric productivity. #### Stage 6: Recovery & formulation Harvesting the fermentation broth, centrifuging the cell mass, and purifying the target chemical through crystallization or chromatography before packaging for B2B distribution.